A new study has highlighted a significant knowledge gap among patients about repeat radiotherapy (reirradiation) as a treatment option for recurrent prostate cancer ...
Non-inferior salvage treatment–free survival at 30 months favored HIFU (90%) versus salvage radical prostatectomy (86%), supporting HIFU as a curative-intent salvage alternative. Functional outcomes ...
Extended follow-up data from the phase 3 study (20 months after reported topline data, median follow-up 58 months) confirmed a statistically ...
Every year, hundreds of thousands of men receive a prostate cancer diagnosis and immediately face a decision that medical ...
ROCHESTER, Minn. — To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic’s Department ...
Approximately one in eight American men will be diagnosed with prostate cancer during their lifetime. For most of them, if ...
Long-term follow-up consistent with earlier report, a hint of benefit in high-grade diseas ...
Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.
From the foods men eat to how surgery is planned and public awareness unfolds, new research presented at the American Urological Association (AUA) Annual Meeting in Washington, DC, shows prostate ...
A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...